These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 13091943)

  • 21. Continued studies in concentrations of para-amino-salicylic acid (PAS) in the blood.
    FROSTAD S
    Acta Tuberc Pneumol Scand; 1961; 41():68-82. PubMed ID: 13895556
    [No Abstract]   [Full Text] [Related]  

  • 22. [Retarding effect of butazolidine on the elimination of PAS].
    CURCHOD B; CHENET C; VIELHAUER S
    Schweiz Z Tuberk; 1954; 11(3):175-84. PubMed ID: 13205179
    [No Abstract]   [Full Text] [Related]  

  • 23. [Paper electrophoretic study of binding of PAS with blood proteins].
    WIEDERMANN D; TOVAREK J
    Lek List; 1954 Jun; 9(12):270-1. PubMed ID: 13213205
    [No Abstract]   [Full Text] [Related]  

  • 24. [Behavior of prothrombinemia in tuberculotic children treated with para-aminosalicylic acid].
    STEGAGNO GA; FABIANI F
    Arch Ital Pediatr Pueric; 1952; 15(5):354-70. PubMed ID: 13031817
    [No Abstract]   [Full Text] [Related]  

  • 25. Elimination of para-aminosalicylic acid in patients with liver disease and renal insufficiency.
    Held H; Fried F
    Chemotherapy; 1977; 23(6):405-15. PubMed ID: 923330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polyvinylpyrrolidone as a drug retardant. III. Effect on sodium p-aminosalicylate.
    GRAHAM WD; TEED H
    J Pharm Pharmacol; 1954 Aug; 6(8):558-61. PubMed ID: 13184435
    [No Abstract]   [Full Text] [Related]  

  • 27. [Studies on the resorption of para-aminosalicylic acid following hyaluronidase administration].
    LAGREZE HW
    Arzneimittelforschung; 1953 Mar; 3(3):139-40. PubMed ID: 13066361
    [No Abstract]   [Full Text] [Related]  

  • 28. [PAS and sodium benzoate; first clinical tests with this combination in the treatment of tuberculosis].
    BERTOLANI F; MALDINI G
    Arch Tisiol Mal Appar Respir; 1950 Oct; 5(10):836-40. PubMed ID: 14811720
    [No Abstract]   [Full Text] [Related]  

  • 29. [Advantage and disadvantage of para-aminosalicylic acid (pas) treatment of tuberculosis].
    FORSGREN E
    Sven Lakartidn; 1950 Dec; 47(52):3024-8. PubMed ID: 14817686
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of tuberculosis with para-aminosalicylic acid; distribution of PAS in the organism].
    STUNDA S
    Bratisl Lek Listy; 1950; 30(8-10):644-8. PubMed ID: 14791814
    [No Abstract]   [Full Text] [Related]  

  • 31. [Measurement of the spreading power of hyaluronidase by means of radioactive isotopes; application to sodium para-aminosalicylate].
    LORMAND C; DESBORDES J; BONET-MAURY P
    Ann Pharm Fr; 1952 Mar; 10(3):173-7. PubMed ID: 14953050
    [No Abstract]   [Full Text] [Related]  

  • 32. [Behavior of gastric secretory function in a group of tuberculous subjects treated with PAS and its sodium salt].
    MONTANARI A; POLLASTRI G
    Minerva Med; 1951 Feb; 42(7):217-8. PubMed ID: 14826602
    [No Abstract]   [Full Text] [Related]  

  • 33. Some cases of tuberculosis cutis treated with para-aminosalicylic acid (PAS).
    LINNROS B
    Acta Derm Venereol; 1951; 31(2):217-8. PubMed ID: 14829181
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effect of PAS and PAS derivatives in experimental tuberculosis of the mouse; a contribution on technic in experimental studies of tuberculosis in the mouse].
    HURNI H; HIRT R; RAGAZ L
    Schweiz Z Pathol Bakteriol; 1951; 14(1):17-33. PubMed ID: 14834840
    [No Abstract]   [Full Text] [Related]  

  • 35. Para-aminosalicylic acid plasma concentrations in children in comparison with adults after receiving a granular slow-release preparation.
    Liwa AC; Schaaf HS; Rosenkranz B; Seifart HI; Diacon AH; Donald PR
    J Trop Pediatr; 2013 Apr; 59(2):90-4. PubMed ID: 23174991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of the prolonged administration of p-(di-n-propylsulfamyl)-benzoic acid (benemid) upon plasma concentrations of para-aminosalicylic acid.
    ISRAEL HL; MICK F; BOGER WP
    Am Rev Tuberc; 1951 Oct; 64(4):454-60. PubMed ID: 14885676
    [No Abstract]   [Full Text] [Related]  

  • 37. [Two cases of multi-drug-resistant pulmonary tuberculosis with para-aminosalicylic acid (PAS)-induced hypothyroidism].
    Mizutani H; Horiba M; Shindoh J; Kimura T; Son M; Wakahara K
    Kekkaku; 2001 Oct; 76(10):667-72. PubMed ID: 11712388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of sodium para-aminosalicylate on oxygen affinity in normal, sickle and fetal human blood.
    Laasberg LH; Hedley-Whyte J; Laver MB
    J Pharmacol Exp Ther; 1976 Nov; 199(2):441-53. PubMed ID: 10430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Blood concentration in the treatment of pulmonary tuberculosis with intravenous PAS].
    HAIZMANN R; HECHT A
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1956; 115(5):365-75. PubMed ID: 13341835
    [No Abstract]   [Full Text] [Related]  

  • 40. [Behavior of various serological tests in tuberculotics treated with PAS and PAS plus isoniazid by intravenous perfusions].
    GAIDA A
    Gazz Med Ital; 1956 Nov; 115(11):348-53. PubMed ID: 13384658
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.